
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Established in 2018, InxMed strives to be a China-based global new drug development engine dedicated to the development of innovative drugs with high probability of success and meaningful value for patients globally by execution of our Best-in-Disease Combination strategy and leveraging China clinical resources. In InxMed, we think differently, because we know the deep understanding of disease biology and value-driven study design are how we differentiate from others. In InxMed, we value the highest efficiency in execution and expeditious generation of PoC data, because we know Vision without execution is hallucination. In InxMed, we believe combination therapy is the future...
Oncology,translation medicine,best-in-disease combination,and innovative drugs
Inxmed operates in the Biotechnology research industry.
Inxmed's revenue is 11m - 100m
Inxmed has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.